tirzepatide safer than semaglutide vs. Tirzepatide: Which GLP-1 Is Right for You? BodyByBariatrics

The SELECT trial (NEJM 2023) showed semaglutide 2.4 mg reduced major adverse cardiovascular events by approximately 20% versus placebo in non-diabetic adults with obesity and established cardiovascular disease

Maintain a Balanced Diet : Eating a diet rich in fiber, lean proteins, and whole grains can help control your appetite and keep blood sugar levels steady

Protein extraction and subsequent LCMS/MS analysis were performed on the labeled samples to identify and quantify differentially expressed proteins

If a patient feels different after starting the medication, it is worth discussing with a healthcare provider

Anyone with any of these should not purchase this deal, as they will not qualify for the program when attempting to redeem with ShedRx